Sapient Therapeutics is a biopharmaceutical company focused on neuroscience drug discovery and early clinical development. Our lead asset (SAP021) has commenced Phase 1 studies and will complete in 2023.
Our leadership team is comprised of industry and cannabinoid veterans, most having previously worked together at GW Pharmaceuticals. Together we want to utilise the experience we gained in cannabinoid development and bring new prescription medicines to patients suffering from serious diseases.
For more information, please email investorrelations@sapienttx.com or visit: https://sapienttx.com
Code: SAP2023TX002
Date of preparation: November 2023
Company Details
- Employees
- 1
- Founded
- -
- Address
- 6 Stratton Street, London,england W1j 8ld,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://sapienttx.com
- Keywords
- Maidenhead.
- HQ
- London, England
Sapient Therapeutics Questions
Sapient Therapeutics's website is http://sapienttx.com
Sapient Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/sapient-therapeutics
Sapient Therapeutics has
1 employees.
View email and phone details for 1
employees at Sapient Therapeutics.
Sapient Therapeutics's industry is
Biotechnology Research
Sapient Therapeutics's top competitors are
Ananda Pharma Plc,
Oceanus Bio,
Sapient,
Quolet Industries,
Avata Biosciences,
Ice Biopharma Gmbh,
Palla Pharma Limited,
Phraktion,
Battle Of The Bio\tech Bands,
Tikun Olam Cannbit Pharmaceuticals Ltd..
Sapient Therapeutics's categories are Biotechnology Research
Sapient Therapeutics's founding year is 2022
